Finance
LifeCell reports Q3 product revenues of $35.1 million
Published in Surgery Litigation and Law Weekly, November 24th, 2006
The increase in product revenues was primarily due to a significant increase in demand for the company's flagship reconstructive surgical product, AlloDerm Regenerative Tissue Matrix, which increased 55% to $29.9 million in the current quarter compared to $19.3 million in the third quarter of 2005. Orthopedic product revenues, which include Graft Jacket and AlloCraftDBM, increased to $2.4 million in the quarter from $2.0 million in the third...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Business Update
Clinical and financial impact of eICU Program presented at American College of Chest Physicians - Personnel
HealthSouth names John P. Whittington general counsel and corporate secretary - Abdominal Aortic Aneurysms
Endologix announces favorable Powerlink five-year follow-up data at TCT 2006 Conference - Adverse Drug Reactions
New research on adverse drug reactions from John Radcliffe Hospital summarized - Aggressive Fibromatosis Therapy
Research on aggressive fibromatosis therapy described by scientists at National Taiwan University, Department of Otolaryngology - Allergy & Immunology
Key molecular signaling switch involved in an allergic disease is identified - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
